2.35. Analysis.
Comparison 2 Oseltamivir versus placebo for prophylaxis, Outcome 35 Adverse events: musculoskeletal body system in adult prophylaxis (on‐treatment).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.